Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
From Cardiac Safety To SAFE PCI Mitchell W. Krucoff, MD, FACC Professor, Medicine/Cardiology Duke University Medical Center Director, Cardiovascular Devices Unit Co-Director, CSRC Duke Clinical Research Institute Cardiac Safety [name of file], 1 Research Consortium Cardiac Safety Research Consortium (CSRC): A Critical Path Public Private Partnership FDA-Duke Memo Of Understanding 2005 Pre-competitive focus Multi-stakeholder perspectives Regulatory/public health landscape “Thinktank-incubator” processes: 1. Barrier identification 2. Prioritization 3. Partnered solutions http://www.fda.gov/oc/initiatives/criticalpath/ 4. Proof-of-concept projects http://www.cardiac -safety.org Trans-Radial Education, Assessment &Training The TREAT Initiative * Obligatory Device-Drug Safety Interaction: Impact of device technique on drug safety *CSRC SOC Approved Research Project www.cardiac-safety.org [name of file], 3 The TREAT Initiative Launch 2010 www.cardiac-safety.org TransRadial Education, Assessment & Therapy: June 2010 Regulatory FDA: CDER CDRH OC OWH Federal NIH AHRQ Academia Duke Harvard Cleveland Clinic Societies ACC SCAI ESC SOLACI Industry Abbott Medtronic Terumo Columbia Emory Cordis/J&J Johns Hopkins The MEDCO Mayo Clinic Wash Hrt Ctr Eli Lilly (Daichi) Sanofi/BMS www.cardiac-safety.org Fruit of pre-competitive PPP (cardiac safety FDA-Duke critical path program) First & only USA PCI study of women Unique public health concern POC for unique research infrastructure http://www.clinicaltrials.gov/ct2/show/NCT01406236?term=safe+pci+for+women&rank=1 CSRC Consensus White Papers www.cardiac-safety.org NIH-NCRI: Linking to the ACC-NCDR for SAFE RCT Efficiency in a “River” of E-Information Index hosp: Pt descriptors Medications Procedural details Adverse events 65% workload reduction Building on SAFE PCI for Women: SAFE STEMI for Seniors Public health: Radial vs. Femoral Intervention Women Seniors Regulatory: OWH IDE extension RCT operations: linked registry efficiencies Short term F/U: NCRI-NCDR Cath PCI Index hosp: descriptors, meds, procedure, SAEs Long term F/U: CMS Claims Data (Seniors) 1 year death, MI, stroke Collaborating Partners: ACC, CSRC, DCRI, FDA-OWH, NIH, Medical Device & Drug Industry ACC, CMS, CSRC, DCRI, FDA-CDRH, NHLBI, NIA, Medical Device & Drug Industry MDEpiNet Dr. Danica Marinac-Dabic (FDA) Dr. Arthur Sedrakyan (Cornell) Dr. Sharon-Lise Normand (Harvard) Dr. Mitchell Krucoff (Duke) http://www/fda/gov/MDEpiNet Overview of Today’s Agenda Plenary: Partnered Approaches to Improving Data Quality & Efficiency SAFE PCI for Women Lunch SAFE STEMI for Seniors Scientific issues Operational issues From Cardiac Safety To SAFE PCI Mitchell W. Krucoff, MD, FACC Professor, Medicine/Cardiology Duke University Medical Center Director, Cardiovascular Devices Unit Co-Director, CSRC Duke Clinical Research Institute Cardiac Safety [name of file], 12 Research Consortium